Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Spinal Stenosis

Spinal Stenosis

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Spinal Stenosis

11 trials tracked for Spinal Stenosis: 5 in phase 3 or 4 and 1 with published results. The most-cited published study has 374 citations.

11Trials tracked
5Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 5 Other / NA 6
  1. Phase 4 Lumbar Epidural Steroid Injections for Spinal Stenosis Multicenter Randomized, Controlled Trial (LESS Trial) Completed · 374 cited
  2. Phase 4 Neurogenic Intermittent Claudication Evaluation Study Completed
  3. Phase 4 Intraoperative Infusion of Precedex to Reduce Length of Stay After Lumbar Spine Fusion Completed
  4. Phase 4 Intermittent Neurogenic Claudication Treatment With APERIUS® Completed
  5. Phase 4 Efficacy of Pregabalin in Patients With Radicular Pain Completed
  6. N/A Retrospective Evaluation of Performance of Coflex® Interlaminer Technology Versus Decompression With or Without Fusion Completed
Show 5 more trials
  1. N/A Clinical Trial Comparing Decompression With and Without Coflex™ Interlaminar Technology Treating Lumbar Spinal Stenosis Completed
  2. N/A Improving Spine Surgical Care With Real-Time Objective Patient Tracking Using the Apple Watch Completed
  3. N/A Assessment of nanOss Bioactive 3D in the Posterolateral Spine Completed
  4. N/A Post-Approval Clinical Trial Comparing the Long Term Safety and Effectiveness Coflex vs. Fusion to Treat Lumbar Spinal Stenosis Completed
  5. N/A Post-op Acetaminophen vs NSAID Use on Lumbar Spinal Fusion Outcomes Completed

Showing the 11 most-cited and recently-updated of 11 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found For clinicians

Spinal Stenosis: what the trials found

Clinical management for spinal stenosis includes various interventions including epidural steroid injections 1. The Aperius™ PercLID™ System showed a mean percentage change from baseline in physical function at one year follow-up of -32.31% and -37.48% (p=0.172) using the Zurich Claudication Questionnaire 3. Additionally, the Aperius® Percutaneous Interspinous Spacer demonstrated a -29.7% mean change in symptom severity at 6 weeks compared to baseline 5, though this was followed by a 26.7% increase in symptom severity at 12 months 5.

Pharmacological and perioperative management trials showed mixed results regarding efficacy. Pregabalin use resulted in pain scores (NRS) of 6 vs 3 (p=0.279), global impression of change of 3.5 vs 3 (p=0.282), and Oswestry Disability Questionnaire scores of 41 vs 20 (p=0.139) at 3 weeks 4. Dexmedetomidine administration did not significantly impact the time required after surgery to reach fitness for hospital discharge (3.2 vs 3.2, p=0.36) 2.

Recent results — preliminary, needs further review

  • A study evaluating the correlation between objective patient measures from an Apple Watch/App and patient-reported outcome measures (SF-36, EQ-5D, PROMIS, NDI, ODI) found no statistically significant correlations (p=0.52394318) 6.

For the clinician treating this condition

  • Epidural steroid injections and the Aperius™ PercLID™ System are established interventions for spinal stenosis; however, the Aperius® Percutaneous Interspinous Spacer showed a significant increase in symptom severity between 6 weeks and 12 months [1, 3, 5].
  • Pharmacological interventions such as Pregabalin and Dexmedetomidine did not show statistically significant improvements in pain scores or recovery timelines in the studied cohorts [2, 4].

AI synthesis of 6 cited trials, updated Jun 25, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
SUZ12 variant identified as a genetic cause of overgrowth phenotype and spinal stenosis
Genetics & Precision Medicine Sys. Review
SUZ12 variant identified as a genetic cause of overgrowth phenotype and spinal stenosis Genetic variant linked to spine issues in overgrowth syndrome
This case report with systematic literature review describes an 11-year-old girl with Imagawa-Matsumoto syndrome (IMMAS) and cervical spinal…
A rare genetic mutation was found causing spinal cord compression in a child with an overgrowth condition.
Frontiers Aug 6, 2026
Unilateral biportal endoscopic laminotomy with bilateral decompression can result in postoperative epidural hematoma
Orthopedics & Sports Medicine Guideline
Unilateral biportal endoscopic laminotomy with bilateral decompression can result in postoperative epidural hematoma New Case Report Highlights Risks in Spinal Stenosis Surgery
This case report describes a 56-year-old male with L3-4 spinal stenosis who developed a postoperative epidural hematoma following UBE-ULBD s…
A rare complication during a specific spinal stenosis procedure highlights the importance of careful surgical techniques and drainage for pa…
Frontiers Jul 7, 2026
Epidural neuroplasty shows potential advantages over pulsed radiofrequency for lumbar radicular pain
Physical Medicine & Rehab Sys. Review
Epidural neuroplasty shows potential advantages over pulsed radiofrequency for lumbar radicular pain Epidural neuroplasty shows potential for lasting lower back pain relief
This network meta-analysis compares pulsed radiofrequency and epidural neuroplasty for lumbar radicular pain. While epidural neuroplasty sho…
A review of 1,229 patients suggests epidural neuroplasty may offer more consistent pain relief than pulsed radiofrequency for chronic back i…
Jun 13, 2026